SOHO Italy 2022 | The challenges in producing efficacious I-O products for AML
Alessandro Isidori
• 24 Oct 2022
Alessandro Isidori, MD, PhD, Marche Nord Hospital, Pesaro, Italy, discusses the challenges in producing efficacious immuno-oncology (I-O) products for acute myeloid leukemia (AML), emphasizing the heterogeneity and immunosuppressive microenvironment observed in this disease. Dr Isidori explains the genetics of AML, and further evaluates the issue of finding agents that selectively target AML cells while preserving healthy hematopoietic cells. This interview took place at The 4th Society of Hematologic Oncology (SOHO) Italy Annual Conference, held in Rome, Italy.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
